Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (3887)	12/18/1997 3:47:00 PM
From: LoLoLoLita	Respond to of 23519

>>Go easy on blankmind. Everybody has a cross to bear >>and he's yours. RT-- OK, I'll give it a try. It's no fun being called a liar over and over again for no good reason. And, unlike all the "pseudonyms" here I use my REAL NAME, and give my geographic location. I do research for a living, and have not been unsuccessful at it. However: I don't want any more malicious and defamatory posts addressed to me, and, if I receive more, I'll forward them to the SI webmistress and ask for her assistance. If anyone is the least bit interested in understanding where I'm coming from .... My goal with the VVUS shares in my taxable account is to hold them for at least 18 months so that when they're sold, the LT cap gains rate will be only 10% (the low rate is because I'm moving to HI to be a beach bum for a few years). I've listened to the entire CC twice already, and spent many hours searching the internet for info on ED treatments, alprostadil, and Muse. My stake in Vivus is larger than any of my other stock positions, with almost all my investments in mutual funds. I believe that Vivus has excellent mgmt, and an excellent product, and the stock is now (@12-13) still extremely undervalued. My only regret over the past week is that I didn't pick up more shares below 12, but I'm unwilling to sell any mutual funds or go on margin to increase my current VVUS position. As far as some of the posters go here who are concerned about the "bad news" 25% revenue shortfall for Q4 as a harbinger of VIV-X. They need to remember that small companies with high growth rates NEVER grow and expand without some stumbles. Vivus would not be opening a factory in Ireland just so they can boost the stock price and then dump all the insider shares on the market, as some of the short-attack sceptics might assume. Cheers, David